PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (March 13 - 17, 2023)

PharmaShots Weekly Snapshots (March 13 - 17, 2023)

March 17, 2023

Samsung Bioepis Reports P-I Study Results of SB17, a Proposed Biosimilar to Stelara

Samsung Bioepis Reports P-I Study Results of SB17, a Proposed Biosimilar to Stelara

March 17, 2023

CANbridge Reports P-I/II Study Results of CAN008 for Glioblastoma Multiforme

CANbridge Reports P-I/II Study Results of CAN008 for Glioblastoma Multiforme

March 17, 2023

Oculis Reports the Completion of Patient Enrolment in P-III Trial (OPTIMIZE) of OCS-01 for the Treatment of Inflammation and Pain

Oculis Reports the Completion of Patient Enrolment in P-III Trial (OPTIMIZE) of OCS-01 for the Treatment of Inflammation and Pain

March 17, 2023

Novartis’ Tafinlar + Mekinist Receives the US FDA’s Approval for BRAF V600E Low-Grade Glioma in Pediatric Patients

Novartis’ Tafinlar + Mekinist Receives the US FDA’s Approval for BRAF V600E Low-Grade Glioma in Pediatric Patients

March 17, 2023

Everest Medicines’ Xerava (eravacycline) Receives NMPA’s Approval for Complicated Intra-Abdominal Infections in Adult Patients

Everest Medicines’ Xerava (eravacycline) Receives NMPA’s Approval for Complicated Intra-Abdominal Infections in Adult Patients

March 17, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us